Please wait a minute...
文章检索
预防医学  2019, Vol. 31 Issue (4): 359-362    DOI: 10.19485/j.cnki.issn2096-5087.2019.04.008
  综述 本期目录 | 过刊浏览 | 高级检索 |
呼吸道合胞病毒监测体系现状及展望
李欢欢1, 程伟2, 刘社兰2(综述), 陈恩富2(审校)
1.浙江医院,浙江 杭州 310013;
2.浙江省疾病预防控制中心
Current situation and prospect of respiratory syncytial virus surveillance system
LI Huan-huan*, CHENG Wei, LIU She-lan, Chen En-fu
*Zhejiang Hospital,Hangzhou,Zhejiang 310013,China
全文: PDF(473 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 呼吸道合胞病毒(RSV)是婴幼儿下呼吸道感染最常见的病原体,给全球带来了严重的疾病负担。开展RSV监测对预防和控制其流行具有重要作用。目前,流行性感冒(流感)监测体系是全球性的,而RSV监测体系是发达国家建立的较多且建立时间较早。RSV监测体系主要表现为两种形式:一种为极少数发达国家建立的标准、特定的RSV监测体系,另一种是大多数国家基于流感监测平台建立的RSV监测体系。本文就RSV监测体系的现状及展望进行综述,为未来RSV监测体系的建设发展提供依据。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
李欢欢
程伟
刘社兰(综述)
陈恩富(审校)
关键词 呼吸道合胞病毒下呼吸道感染监测体系    
Abstract:Respiratory syncytial virus(RSV)is the most common pathogen of lower respiratory infection among infants,leading to serious burden of disease all over the world. The surveillance of RSV plays an important role in preventing and controlling its epidemic. At present,the surveillance systems of RSV are not as global as that of influenza,which have been established much more and earlier in the developed countries. The RSV surveillance system are manifested in two types:specific and standard surveillance systems established by very few developed countries and surveillance systems based on the influenza surveillance established by most other countries. This article reviews the current status and prospect of RSV surveillance systems to provide reference for the development of RSV surveillance system in the future.
Key wordsRespiratory syncytial virus    Lower respiratory infection    Surveillance system
收稿日期: 2018-11-19      修回日期: 2018-12-27      出版日期: 2019-04-02
中图分类号:  R183.3  
基金资助:2017年浙江省自然科学基金项目(Y17H260003); 浙江医院科研项目(2014YJ025)
通信作者: 陈恩富,E-mail:enfchen@cdc.zj.cn   
作者简介: 李欢欢,硕士,医师,主要从事科研管理工作
引用本文:   
李欢欢, 程伟, 刘社兰(综述), 陈恩富(审校). 呼吸道合胞病毒监测体系现状及展望[J]. 预防医学, 2019, 31(4): 359-362.
LI Huan-huan, CHENG Wei, LIU She-lan, Chen En-fu. Current situation and prospect of respiratory syncytial virus surveillance system. Preventive Medicine, 2019, 31(4): 359-362.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2019.04.008      或      http://www.zjyfyxzz.com/CN/Y2019/V31/I4/359
[1] SCHELTEMA N M,GENTILE A,LUCION F,et al.Global respiratory syncytial virus-associated mortality in young children(RSV GOLD):a retrospective case series[J]. The Lancet Glob Health,2017,5(10):e984-e991.
[2] SHI T,MCALLISTER D A,O'BRIEN K L,et al. Global,regional,and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015:a systematic review and modelling study[J]. Lancet,2017,390(10098):946-958.
[3] ZHANG Y,YUAN L,ZHANG Y,et al.Burden of respiratory syncytial virus infections in China:systematic review and meta-analysis[J]. J Glob Health,2015,5(2):020417.
[4] CAMPBELL H,BONT L,NAIR H.Respiratory syncytial virus(RSV)disease-new data needed to guide future policy[J]. J Glob Health,2015,5(2):020101.
[5] World Health Organization.WHO informal consultation on surveillance of RSV on the Global Influenza Survellance and Response System(GISRS)Platform[R]. Geneva:World Health Organization,2015:1-21.
[6] BREIMAN R F,VAN BENEDEN C A,FARNON E C. Surveillance for respiratory infections in low- and middle-income countries:experience from the Centers for Disease Control and Prevention's Global Disease Detection International Emerging Infections Program[J]. J Infect Dis,2013,208(S3):167-172.
[7] KIM L,RHA B,ABRAMSON J S,et al.Identifying gaps in respiratory syncytial virus disease epidemiology in the United States prior to the introduction of vaccines[J]. Clin Infect Dis,2017,65(6):1020-1025.
[8] PANOZZO C A,STOCKMAN L J,CURNS A T,et al.Use of respiratory syncytial virus surveillance data to optimize the timing of immunoprophylaxis[J]. Pediatrics,2010,126(1):e116-e123.
[9] ROSE E B,WHEATLEY A,LANGLEY G,et al.Respiratory syncytial virus seasonality - United States,2014-2017[J]. Morb Mortal Wkly Rep,2018,67(2):71-76.
[10] KANOU K,ARIMA Y,KINOSHITA H,et al.Respiratory Syncytial Virus Surveillance System in Japan:assessment of recent trends,2008-2015[J]. Jpn J Infect Dis,2018,71(3):250-255.
[11] TANIGUCHI K,HASHIMOTO S,KAWADO M,et al. Overview of infectious disease surveillance system in Japan,1999-2005[J]. J Epidemiol,2007(S17):3-13.
[12] MEERHOFF T J,FLEMING D,SMITH A,et al.Surveillance recommendations based on an exploratory analysis of respiratory syncytial virus reports derived from the European Influenza Surveillance System[J]. BMC Infect Dis,2006(6):128.
[13] BROBERG E K,WARIS M,JOHANSEN K,et al.Seasonality and geographical spread of respiratory syncytial virus epidemics in 15 European countries,2010 to 2016[J]. Euro Surveill,2018,23(5):17-00284.
[14] MEERHOFF T J,MOSNIER A,SCHELLEVIS F,et al.Progress in the surveillance of respiratory syncytial virus(RSV)in Europe:2001-2008[J]. Euro Surveill,2009,14:19346.
[15] HUO X,FANG B,LIU L,et al.Clinical and epidemiologic characteristics of respiratory syncytial virus infection among children aged <5 years,Jingzhou City,China,2011[J]. J Infect Dis,2013, 208(S 3):184-188.
[16] ROWLINSON E,DUEGER E,TAYLOR T,et al.Incidence and clinical features of respiratory syncytial virus infections in a population-based surveillance site in the Nile Delta Region[J]. J Infect Dis,2013,208(S3):189-196.
[17] NAORAT S,CHITTAGANPITCH M,THAMTHITIWAT S,et al.Hospitalizations for acute lower respiratory tract infection due to respiratory syncytial virus in Thailand,2008-2011[J]. J Infect Dis,2013,208(S3):238-245.
[18] MCCRACKEN J P,PRILL M M,ARVELO W,et al.Respiratory syncytial virus infection in Guatemala,2007-2012[J]. J Infect Dis,2013,208(S3):197-206.
[19] BIGOGO G M,BREIMAN R F,FEIKIN D R,et al.Epidemiology of respiratory syncytial virus infection in rural and urban Kenya[J]. J Infect Dis,2013,208(S3):207-216.
[20] MOYES J,COHEN C,PRETORIUS M,et al.Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children,2010-2011[J]. J Infect Dis,2013,208(S3):217-226.
[21] LU L,YAN Y,YANG B,et al.Epidemiological and clinical profiles of respiratory syncytial virus infection in hospitalized neonates in Suzhou,China[J]. BMC Infect Dis,2015(15):431.
[22] World Health Organization.WHO Expert Working Group Meeting on RSV surveillance based on the GISRS Platform[R]. Geneva:World Health Organization,2016:1-13.
[23] World Health Organization.WHO strategy to pilot global respiratory syncytial virus surveillance based on the Global Influenza Survellance and Response System(GISRS)[R]. Geneva:World Health Organization,2017:1-31.
[24] HALL C B,WEINBERG G A,IWANE M K,et al.The burden of respiratory syncytial virus infection in young children[J]. N Engl J Med,2009,360(6):588-598.
[25] SAHA S,PANDEY B G,CHOUDEKAR A,et al.Evaluation of case definitions for estimation of respiratory syncytial virus associated hospitalizations among children in a rural community of northern India[J]. J Glob Health,2015,5(2):010419.
[26] RHA B,DAHL R M,MOYES J,et al. Performance of surveillance case definitions in detecting respiratory syncytial virus infection among young children hospitalized with severe respiratory illness-South Africa,2009-2014[J]. J Pediatric Infect Dis Soc,2018(2018-06-21)[2018-11-19]. https://www.ncbi.nlm.nih.gov/ pubmed/29931284.
[27] FLEMING D M,TAYLOR R J,LUSTIG R L,et al.Modelling estimates of the burden of respiratory syncytial virus infection in adults and the elderly in the United Kingdom[J]. BMC Infect Dis,2015(15):443.
[28] GAMINO-ARROYO A E,MORENO-ESPINOSA S,LLAMOSAS- GALLARDO B,et al. Epidemiology and clinical characteristics of respiratory syncytial virus infections among children and adults in Mexico[J]. Influenza Other Respir Viruses,2016,11(1):48-56.
[29] HARVALA H,CARNAHAN A,AXELSSON S,et al. Evaluation of the national laboratory-based surveillance system for respiratory syncytial virus in Sweden,2015-2016[J]. J Clin Virol,2018(104):11-15.
[1] 任帆, 施妍尔, 嵇龙飞, 蔡云祥. 湖州市儿童急性下呼吸道感染病原体流行特征[J]. 预防医学, 2021, 33(6): 595-598.
[2] 杨晓芳,谢建华,章秋霞. 下呼吸道感染主要病原菌耐药性分析[J]. 预防医学, 2018, 30(9): 930-932.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed